Clinical Trial Update: H7N9 Mix and Match With MF59 in Healthy Elderly Persons [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an H7N9 influenza vaccine with MF59 adjuvant in healthy elderly adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• H7N9 vaccine with MF59 adjuvant (H7N9 influenza vaccine with MF59 adjuvant)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza | Phase 2 | Status: COMPLETED